CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 20 enrolled
Drug / intervention
graft versus host disease prophylaxis/therapy +2 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01616056
NCT01616056Phase 2Completed
CompareCT.gov

A Single Center Phase II Study of Bandage Lenses for Ocular Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Fred Hutchinson Cancer Center·interventional·Posted Jun 11, 2012·Updated Jul 17, 2017

In Brief

A Phase 2 clinical trial evaluating graft versus host disease prophylaxis/therapy, questionnaire administration, and 1 other intervention for Graft Versus Host Disease and Ophthalmologic Complications. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This phase II clinical trial studies how well bandage lenses work in treating patients with ocular graft versus host disease. Bandage lenses may be helpful in relieving eye symptoms and damage caused by eye graft versus host disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGraft Versus Host Disease, Ophthalmologic Complications
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 11, 2012
Enrollment StartJun 1, 2012
Primary CompletionOct 1, 2014
Study CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 14.1 years ago

Interventions

graft versus host disease prophylaxis/therapybiological

Wear bandage lenses

questionnaire administrationother

Ancillary studies

optical coherence tomographyprocedure

Optional ancillary studies